BR112014008657A2 - composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina - Google Patents

composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina

Info

Publication number
BR112014008657A2
BR112014008657A2 BR112014008657A BR112014008657A BR112014008657A2 BR 112014008657 A2 BR112014008657 A2 BR 112014008657A2 BR 112014008657 A BR112014008657 A BR 112014008657A BR 112014008657 A BR112014008657 A BR 112014008657A BR 112014008657 A2 BR112014008657 A2 BR 112014008657A2
Authority
BR
Brazil
Prior art keywords
composition
insulin resistance
reducing
increasing
insulin sensitivity
Prior art date
Application number
BR112014008657A
Other languages
English (en)
Inventor
Garcia- Rodenas Clara
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112014008657A2 publication Critical patent/BR112014008657A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

resumo patente de invenção: "composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina". a presente invenção refere-se a uma composição compreendendo pelo menos um ácido graxo poli-insaturado de cadeia longa, pelo menos um probiótico e uma mistura de oligossacarídeos, a dita mistura contendo pelo menos um de lacto-n-neotetraose (lnnt) e lacto-n-tetraose (lnt), pelo menos um oligossacarídeo n-acetilado diferente de lnnt e lnt, pelo menos um oligossacarídeo sialilado e pelo menos um oligossacarídeo neutro, para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina. esta composição opcionalmente compreende ainda 2'-fucosil lactose (fl). esta composição é particularmente adaptada para o uso em lactentes que nasceram pré-termo e/ou que experienciaram iugr, em mulheres grávidas sofrendo de diabete gestacional e em crianças, adolescentes, e adultos sofrendo de resistência à insulina e/ou diabete tipo ii.
BR112014008657A 2011-10-18 2012-10-15 composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina BR112014008657A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11185603 2011-10-18
PCT/EP2012/070356 WO2013057061A1 (en) 2011-10-18 2012-10-15 Composition for use in increasing insulin sensitivity and/or reducing insulin resistance

Publications (1)

Publication Number Publication Date
BR112014008657A2 true BR112014008657A2 (pt) 2017-04-25

Family

ID=47046594

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014008657A BR112014008657A2 (pt) 2011-10-18 2012-10-15 composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina

Country Status (13)

Country Link
US (1) US9636367B2 (pt)
EP (1) EP2768314B1 (pt)
CN (1) CN103889240B (pt)
AU (1) AU2012325072B2 (pt)
BR (1) BR112014008657A2 (pt)
CL (1) CL2014000832A1 (pt)
ES (1) ES2560023T3 (pt)
MX (1) MX350436B (pt)
PL (1) PL2768314T3 (pt)
PT (1) PT2768314E (pt)
RU (1) RU2604503C2 (pt)
WO (1) WO2013057061A1 (pt)
ZA (1) ZA201403593B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3082473A2 (en) * 2013-12-19 2016-10-26 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
WO2016091265A1 (en) 2014-12-08 2016-06-16 Glycom A/S Synthetic composition for treating metabolic disorders
US10881674B2 (en) * 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
ES2886951T3 (es) 2015-09-14 2021-12-21 Glycom As Composición para su uso en la modulación de la microbiota
US11957148B2 (en) 2015-12-15 2024-04-16 Societe Des Produits Nestle S.A. Mixture of human milk oligosaccharides(HMOs)
ES2862774T3 (es) * 2016-04-11 2021-10-07 Nestle Sa Nutrición infantil que proporciona beneficios metabólicos
EP3471562A4 (en) * 2016-06-15 2020-07-29 Glycom A/S SYNTHETIC COMPOSITIONS WITH MOTHER MILK OLIGOSACCHARIDES FOR THE PREVENTION AND TREATMENT OF DISEASES
CA3035972A1 (en) 2016-09-07 2018-03-15 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of insulin resistance
TWI658791B (zh) * 2017-09-25 2019-05-11 愛之味股份有限公司 具有調節血脂、改善腸道菌叢及提升免疫力功能的富含寡醣乳製品及其製法
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN111683666A (zh) * 2017-12-22 2020-09-18 格礼卡姆股份公司 预防或减少伤害感受的包含hmo的组合物
CN111954536A (zh) * 2018-03-23 2020-11-17 森永乳业株式会社 用于预防学龄期及之后的高血糖引起的疾病的婴幼儿用组合物
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
EP3846830A4 (en) 2018-09-05 2022-07-06 Solarea Bio, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
BR112021007646A2 (pt) * 2018-11-30 2021-09-14 Société des Produits Nestlé S.A. Composição nutricional para bebês para uso na melhora de maturação pancreática e de biossíntese de insulina
CN111165825A (zh) * 2019-07-17 2020-05-19 江苏西宏生物医药有限公司 一种术前经肠营养组合物
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6946451B2 (en) * 2002-02-04 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Insulin secretion promoter
US6942857B2 (en) * 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
GB0302929D0 (en) * 2003-02-10 2003-03-12 Inst Of Child Health Nutrient composition
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
RU2417712C2 (ru) * 2005-12-23 2011-05-10 Н.В. Нютрисиа Питательная композиция для младенцев, предназначенная для предупреждения ожирения
BRPI0707620A2 (pt) * 2006-02-10 2011-05-10 Nestec Sa mistura de oligossacarÍdeo
ES2553636T3 (es) * 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
WO2009060073A1 (en) * 2007-11-08 2009-05-14 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
EP2143341A1 (en) * 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
RU2559646C2 (ru) * 2009-04-01 2015-08-10 Нестек С.А. Снижение риска ожирения
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers

Also Published As

Publication number Publication date
PL2768314T3 (pl) 2016-05-31
ES2560023T3 (es) 2016-02-17
CN103889240B (zh) 2016-09-14
US20140286909A1 (en) 2014-09-25
AU2012325072A1 (en) 2014-03-13
US9636367B2 (en) 2017-05-02
RU2014119903A (ru) 2015-11-27
ZA201403593B (en) 2016-09-28
CN103889240A (zh) 2014-06-25
MX350436B (es) 2017-09-06
AU2012325072B2 (en) 2015-12-03
RU2604503C2 (ru) 2016-12-10
CL2014000832A1 (es) 2014-08-22
AU2012325072A2 (en) 2014-05-29
EP2768314A1 (en) 2014-08-27
MX2014004724A (es) 2015-02-05
PT2768314E (pt) 2016-02-17
WO2013057061A1 (en) 2013-04-25
EP2768314B1 (en) 2015-11-25

Similar Documents

Publication Publication Date Title
BR112014008657A2 (pt) composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina
BR112014008944A2 (pt) composição para uso no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
De Curtis et al. Extrauterine growth restriction in very‐low‐birthweight infants
Krabbendam et al. Relationship between DHA status at birth and child problem behaviour at 7 years of age
BRPI0820175B8 (pt) uso de oligossacarídeos contendo n-acetillactosamina para maturação de respostas imunes em neonatos.
BR112017017840A2 (pt) composição compreendendo sialil-lactose para uso na melhora das capacidades de aprendizado e função de memória
BRPI0513500C8 (pt) Uso de equivalentes de aspartato e composição nutricional ou farmacêutica
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112013010021A2 (pt) combinações farmacêuticas para o tratamento de distúrbios metabólicos.
BR112014008425A2 (pt) composição para o uso na promoção de angiogênese intestinal e de absorção de nutriente e de tolerância a alimentação enteral e/ou na prevenção e/ou no tratamento de inflamação intestinal e/ou na recuperação após a lesão e a cirurgia intestinal
BR112014010953A2 (pt) fórmulas infantis e seus usos
WO2012092157A3 (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
BR112012013766A2 (pt) "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite"
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
BR112015014420A2 (pt) oligossacarídeos do leite humano para melhorar sintomas de estresse
MY155717A (en) Nutritional composition containing oligosaccharide mixture
BR112018013538A2 (pt) composições compreendendo 2fl e lnnt para uso em bebês ou crianças pequenas para evitar a obesidade, ou comorbidades relacionadas, em fases posteriores da vida
BR112013029269A8 (pt) combinação farmacêutica para uso na indução de perda de peso em pacientes com diabetes tipo 2 e/ou para prevenir o ganho de peso em pacientes com diabetes tipo 2
BR112014009097A2 (pt) composição para uso na promoção de crescimento de osso saudável e/ou na prevenção e/ou tratamento das doenças dos ossos
BR112013026573A2 (pt) fórmula de lactente para uso na prevenção de doenças cardiovasculares
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
BR112014009225A2 (pt) uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes
BR112014007829A2 (pt) composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio
BR112022022781A2 (pt) Uso de oligossacarídeos de leite humano em composições nutricionais para melhorar desenvolvimento ósseo e/ou resistência óssea
BR112014000773A8 (pt) Composições de nicotinamida e uso terapêutico das mesmas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/745 (2015.01), A23L 33/115 (2016.01), A23L

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B350 Update of information on the portal [chapter 15.35 patent gazette]